This partnership significantly increases global access to XenoSTART’s high-demand tumor models. Scientist.com, the leading R&D procurement orchestration platform for the life sciences, today announced a major expansion of its Tumor Model Finder (TMF) following a strategic partnership with XenoSTART, a global leader in patient-derived xenograft (PDX) model development and testing. The addition of hundreds of…
Compound to be evaluated as a potentially best-in-class treatment for rare genetic forms of obesity and hypothalamic obesity, as well as part of the treatment regimen for adult obesity patients In preclinical studies, the molecule demonstrated high selectivity, a broad therapeutic window, and a favorable safety profile compared to existing treatments and those in development…
AIRS Medical, creator of the AI-powered MRI enhancement solution SwiftMR, is expanding its global footprint through strategic partnerships and a surge in customer growth across Latin America. In the past six months alone, more than 150 imaging centers in Brazil have adopted SwiftMR, underscoring the region’s increasing demand for faster, AI-enhanced MRI. Scaling SwiftMR in Latin America In 2024, AIRS…
Latest release introduces industry-leading AI performance, optimized workflow integration, and enhanced surgeon usability to streamline imaging-to-intervention planning SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision in breast cancer treatment, today announced its third FDA 510(k) clearance for TumorSight Viz. The clearance expands the platform’s ability to convert standard breast MRI into intuitive,…
MarketNewsUpdates News Commentary Artificial Intelligence (AI) algorithms are revolutionizing the way retina images are analyzed for detecting conditions such as age-related macular degeneration (AMD) and diabetic retinopathy. These advanced algorithms often achieve diagnostic accuracies that equal or surpass human experts, especially in complex cases. This capability not only enhances diagnostic precision but also supports clinicians in…
Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to develop “aiGait” powered by Uvance, a solution that leverages Fujitsu’s advanced skeleton recognition AI technology to detect gait pattern abnormalities, and provide gait quantization to healthcare professionals to support the early diagnosis of dementia and Parkinson’s…
IntelliBlate is now CE-marked and ready for launch in Europe, offering clinicians a precision-driven, minimally invasive treatment option integrated with Siemens Healthineers’ image-guided therapy technologies. Varian, a Siemens Healthineers company, today announced the European launch of IntelliBlate, its next generation microwave ablation solution, for the treatment of soft tissue tumors. Now CE-marked, IntelliBlate represents a…